2 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow Trypanosomiasis: new trials by email Literature Review of Trypanosomiasis trials Research Report on Trypanosomiasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease 40 mg Atorvastatin/day for 120 days P.O., Atorvastatin 80, Placebo - Chronic Chagas Disease | Phase 2 | Terminated | Juan D. Maya | 300 | 2021-10-12 | 2024-09-19 |
| Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda Eflornithine plus Nifurtimox combination therapy - Trypanosomiasis, African | Phase 2 / Phase 3 | Terminated | Epicentre | 31 | 2002-10-01 | 2007-06-21 |
Chagas Disease (1) · Inflammation (1) · Trypanosomiasis, African (1)
Euglenozoa Infections (2) · Infections (2) · Parasitic Diseases (2) · Protozoan Infections (2) · Vector Borne Diseases (2) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Eflornithine (1)
Epicentre (1) · Juan D. Maya (1)
Chile (1) · Uganda (1)
Gerardo Priotto, MD MPH (1) · Juan D. Maya, Ph.D. (1) · Patrice Piola, MD MSc (1)